Pharma shares slump after Trump price threat
World
By
AFP
| Aug 01, 2025
Shares in European pharmaceutical firms slumped on Friday following a threat by President Donald Trump to punish them if they don't lower prices for medicines in the United States.
Shares in Novo Nordisk, the Danish maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, saw shares drop 4.5 per cent shortly after trading got under way in Copenhagen.
Shares in Britain's AstraZeneca fell 2.8 per cent in London, while Sanofi fell 1.1 per cent in Paris.
Meanwhile, shares in Novartis shed 0.9 per cent and Roche 1.0 per cent after Trump announced Swiss goods will face a 39 per cent tariff starting next week.
READ MORE
How Kenyan banks are losing billions to fraud
Why US ballooning public debt is a key concern for Kenya
Nairobi Expressway contractor to shoulder Sh6.9b tax bill
KEBS on the spot over plans to engage firm to validate vehicle importation papers
Call for business leaders to adopt AI for increased productivity
Tata Chemicals to pause Kenya operations for major upgrade
Mombasa port maintains grip as key hub for Uganda
Safaricom Hook holds training forums for youth in Western Kenya
Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world.
In letters to 17 drug companies published on his platform Truth Social, Trump said he wants the firms to work with his administration to institute a series of changes within 60 days.
"If you refuse to step up, we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices," Trump wrote without specifying what the consequences would entail.
Trump is following up on an executive order he signed in May to address US drug prices that are among the highest in the world -- more than three times what people in similarly developed countries pay, the White House said Thursday.